Repositorio Dspace

Listar01.01. Investigación y comunicación científica por tema "Seasons"

Listar01.01. Investigación y comunicación científica por tema "Seasons"

Ordenar por:Orden:Resultados:

  • COVID-19 Vaccine Effectiveness in Autumn and Winter 2022 to 2023 Among Older Europeans 
    Delaunay, Charlotte-Laniece; Mazagatos, Clara; Martínez-Baz, Ivan; Turi, Gergo; Goerlitz, Luise; Domegan, Lisa; Meijer, Adam; Rodrigues, Ana-Paula; Seve, Noemie; Ilic, Maja; Latorre-Margalef, Neus; Lazar, Mihaela; Maurel, Marine; Melo, Aryse; Andreu-Ivorra, Blanca; Casado, Itziar; Horvath, Judit-Krisztina; Buda, Silke; Bennett, Charlene; de-Lange, Marit; Guiomar, Raquel; Enouf, Vincent; Mlinaric, Ivan; Hagey, Tove-Samuelsson; Dinu, Sorin; Rumayor, Mercedes; Castilla, Jesús; Oroszi, Beatrix; Duerrwald, Ralf; O'Donnell, Joan; Hooiveld, Mariette; Gómez, Verónica; Falchi, Alessandra; Filipovic, Sanja-Kurecic; Dillner, Lena; Popescu, Rodica; Bacci, Sabrina; Kaczmarek, Marlena; Kissling, Esther (AMER MEDICAL ASSOC, 2024-07-01)
    IMPORTANCE: In the context of emerging SARS-CoV-2 variants or lineages and new vaccines, it is key to accurately monitor COVID-19 vaccine effectiveness (CVE) to inform vaccination campaigns. OBJECTIVE: To estimate the ...
  • Effectiveness of catch-up and at-birth nirsevimab immunisation against RSV hospital admission in the first year of life: a population-based case-control study, Spain, 2023/24 season 
    Núñez, Olivier; Olmedo, Carmen; Moreno-Pérez, David; Lorusso, Nicola; Fernández-Martínez, Sergio; Pastor-Villalba, Pedro-Eliseo; Gutiérrez, Ángeles; García, Marcos-Alonso; Latasa, Pello; Sancho, Rosa; Mendioroz, Jacobo; Martínez-Marcos, Montserrat; Muñoz-Platon, Enrique; García-Rivera, María-Victoria; Pérez-Martínez, Olaia; Álvarez-Gil, Rosa; Wagner, Eva-Rivas; López-González-Coviella, Nieves; Zornoza-Moreno, Matilde; Barranco-Boada, María-Isabel; Pacheco, M-del-Carmen; Álvarez-Río, Virginia; Jaume, Miguel-Fiol; Arance, Roxana-Morey; Sancho, Begoña-Adiego; Méndez-Díaz, Manuel; Batalla-Rebollo, Noa; Andreu, Cristina; Castilla, Jesús; García-Cenoz, Manuel; Fernández-Ibáñez, Ana; Huerta-Huerta, Marta; Ibáñez-Pérez, Ana-Carmen; Berradre-Saenz, Belén; Lamas, Joaquín; Hermoso, Luisa; Casado-Cobo, Susana; Galán-Cuesta, Manuel; Montenegro, Sara; Domínguez, María; Jarrin, Inmaculada; Limia, Aurora; Pastor-Barriuso, Roberto; Monge, Susana (EUR CENTRE DIS PREVENTION & CONTROL, 2025-02-06)
    BackgroundRespiratory syncytial virus (RSV) causes substantial morbidity in infants < 1 year. In October 2023, Spain recommended the monoclonal antibody nirsevimab to all children born since 1 April 2023, at birth or as ...
  • Effectiveness of influenza vaccines in children aged 6 to 59 months: a test-negative case-control study at primary care and hospital level, Spain 2023/24Effectiveness of influenza vaccines in children aged 6 to 59 months: a test-negative case-control stud 
    Pérez-Gimeno, Gloria; Mazagatos, Clara; Lorusso, Nicola; Basile, Luca; Martínez-Pino, Isabel; Corpas-Burgos, Francisca; Batalla-Rebolla, Noa; Rumayor, Mercedes-Belén; Andreu-Ivorra, Blanca; Giménez-Durán, Jaume; Castrillejo-Pérez, Daniel; Guiu-Canete, Inés; Huerta-Huerta, Marta; García-Becerril, Marta; Ramos-Marín, Violeta; Casas, Inmaculada; Pozo, Francisco; Monge, Susana (EUR CENTRE DIS PREVENTION & CONTROL, 2024-10)
    During 2023/24, all children aged 6 to 59 months were targeted for seasonal influenza vaccination in Spain nationally. Using a test-negative case-control design with sentinel surveillance data, we estimated adjusted influenza ...
  • Effectiveness of the autumnal COVID-19 vaccine dose during the winter and summer waves of the 2023/24 season in Spain 
    Rojas-Benedicto, Ayelen; Perez-Gimeno, Gloria; Mendioroz, Jacobo; Corral, Irene Pedrosa; Torrijos, Miriam Lopez; Rumayor, Mercedes; Lopez, Ma Angeles Rafael de la Cruz; Wagner, Eva Rivas; de Laiglesia, Ma Angel Valcarcel; Canete, Ines Guiu; Ibanez, Ana Fernandez; Martinez, Olaia Perez; Dopido, Juan Antonio Linares; Latasa, Pello; Torres-Juan, Marta; Recio, Ma Jesus Rodriguez; Castrillejo, Daniel; Raymundo, Luis Javier Viloria; Berrios, Ninoska Lopez; Vazquez-Moron, Sonia; Monge, Susana (TAYLOR & FRANCIS LTD, 2025-12-31)
    BACKGROUND: We estimated vaccine effectiveness (VE) of the COVID-19 monovalent XBB.1.5 vaccine recommended in Spain in October 2023 for ?60-year-olds against medically attended COVID-19 and COVID-19 hospitalization, during ...
  • Establishing Epidemic and Intensity Thresholds After a Major Change in Respiratory Virus Surveillance in Spain in 2020 
    Puerto, Ana-María; Lozano, José-Eugenio; Lozano, Marcos; Basile, Luca; Naveira-Barbeito, Gael; Guiu-Canete, Inés; Linares-Dopido, Juan-Antonio; Fernández-Ibáñez, Ana; Ibáñez-Pérez, Ana-Carmen; Castrillejo, Daniel; Rivas-Wagner, Eva; Valcárcel-de-la-Iglesia, María-Ángel; Pérez-Morilla, Esteban; Martínez-Pino, Isabel; Vega, Tomas; Monge, Susana (WILEY, 2025-09)
    OBJECTIVES: We estimated acute respiratory infections (ARIs) and influenza-like illness (ILI) thresholds for SiVIRA, a new integrated surveillance system set up in Spain in 2020. METHODS: We retrospectively extracted ...
  • Relative Efficacy, Effectiveness and Safety of Newer and/or Enhanced Seasonal Influenza Vaccines for the Prevention of Laboratory-Confirmed Influenza in Individuals Aged 18 years and Over: Update of a Systematic Review 
    Askar, Mona; Ali, Karam-Adel; Batke, Madeleine; Brugger, Timo; Falman, Annika; Robertson, Anna-Hayman; Pérez-Martín, Jaime-Jesús; Johansen, Kari; de-Jonge, Jorgen; Krause, Tyra-Grove; Kuelper-Schiek, Wiebe; Meerpohl, Joerg-J; Melidou, Angeliki; Nohynek, Hanna; Olmedo, Carmen; Olsson, Kate; Pavlopoulou, Ioanna; Piechotta, Vanessa; Rubin, Johanna; Schlaberg, Johanna; Schmucker, Christine; Siemens, Waldemar; Stratil, Jan; Ucakar, Veronika; Wichmann, Ole; Harder, Thomas (WILEY, 2025-03)
    We performed an update (last search: 24 July 2023) of a systematic review on relative efficacy/effectiveness (rVE) and safety of newer/enhanced seasonal influenza vaccines in comparison with standard influenza vaccine or ...
  • Two-season effectiveness of a single nirsevimab dose against RSV hospitalisation in healthy term-born infants: a population-based case-control study, Spain, October 2023 to March 2025 
    Núñez, Olivier; Juaneda, Juan; Martínez-Marcos, Montserrat; Muñoz-Platón, Enriqueta; Rivas-Wagner, Eva; Santiago-Pérez, María-Isolina; Álvarez-Río, Virginia; Zornoza-Moreno, Matilde; Fernández-Ibáñez, Ana; Pérez-Suárez, Gisselle; Lorono-Ortiz, Gorka; Egues, Nerea; Berradre-Saenz, Belén; Cuesta-Franco, María-de-los-Ángeles; Casado-Cobo, Susana; Domínguez-Padilla, María; Castrillejo, Daniel; Mínguez-Santiyan, Ana; Basile, Luca; Rafael-de-la-Cruz-López, María-Ángeles; Sanabria-Curbelo, Diana; Pérez-Martínez, Olaia; Rodríguez-Recio, M-Jesús; Duró-Gómez, Lourdes; Alonso-Vigil, María-del-Pilar; Méndez-Díaz, Manuel-A; Sancho, Rosa; Castilla, Jesus; Ibáñez-Pérez, Ana-Carmen; Batalla-Rebollo, Noa; Sánchez-Piorno, Lucía; López-Berrios, Ninoska; Lamas, Joaquín; Olmedo, Carmen; Monge, Susana; Pastor-Barriuso, Roberto (EUR CENTRE DIS PREVENTION & CONTROL, 2026-03-05)
    BACKGROUNDIn autumn 2023, Spain recommended nirsevimab to all infants born after 1 April 2023, as catch-up or at-birth immunisation.AIMWe estimated effectiveness of a single nirsevimab dose against respiratory syncytial ...

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta